Productive Drugs Not even Price In the Cheap Cash Individual

There have been many new biological drugs approved by the FDA to take care of psoriasis since 2003 as an example of an inflated drug price that most lower income people can’t get access to because Medicaid and Medicare won’t purchase them because of the skyrocketing prices. The newest blood thinner “Eliquis” is covered by Medicaid and Medicare at $200 a bottle. The COPD inhalers which are fairly new may also be covered by the government without hesitation in the region of $150 a pop. Some states purchase the very costly $400 and above hearing aids and some don’t. So just why aren’t the newest biological drugs that came out to take care of psoriasis since 2003 covered by the government?

I suppose this is one moment where I’m planning to answer the question I simply asked with this articles readers. In the aforementioned linked article I posted to go with this particular article mcdougal states these biological drugs to take care of psoriasis will NOT be available to people that are on Medicaid and Medicare as a result of price. All the drug companies who have created their own biological psoriasis treatments have pushed people on Medicaid and Medicare from receiving treatment with one of these drugs through the high cost of the drugs. Medicare Part D prescription drug plan will probably pay the bulk cost of “biological’s” nevertheless the co pay is between $1200 and $5000 which still keeps folks from having the biological’s.

The spin is a few of these biological drug companies have programs to provide the drugs absolve to low income patients who have private insurance only. Drug companies have stated in many articles I’ve read when the patients have Medicare or Medicaid they’ll NOT be qualified to receive the free programs.

Quote From GoodRX.com: The lowest GoodRx price for the most frequent version of Humira is just about $5,130.76, 38% off the average retail price of $8,309.04.

These biological psoriasis treatments are not life saving so Medicare and Medicaid don’t recognize the inflated cost by drug companies as a required expense. The drug companies know this and are interested this way. Back in 2003 when these biological psoriasis treatments were entering the drug marketplace they certainly were affordable and insurance companies found the expenses if a reasonable deductible was paid. After 2012 the insurance companies started to get rid of people who have psoriasis since the payouts on the biological treatments were rising and getting extremely expensive.
The “Epipen Injector” used to take care of heroin overdoses was attacked viciously by the U.S. government when the master of the business jacked up the cost so high only the really wealthy could afford them. Medicaid and Medicare in some states do cover generic Epipen’s but reject brand names. I’ve arrived at my conclusion about why this and other high drug prices are happening that keep some of those drugs from the reach of many people that are on Medicare and Medicaid.

Come ON! of course it’s collusion between the “Big Pharma” drug industry and members of congress. But once the collusion deals lose their freshness it’s the drug industry that is forced to take the fall.

When these scams to gain personal wealth arrived at light as in the opioid epidemic that is ongoing now where billions of dollars are now being paid out by the drug companies to the states our congressional representatives who profited from opioids though insider trading investments walk around without possibility of repercussion for their involvement in the scheme.

If you look at Canada which really is a country where government has to cover ALL healthcare costs you might find the lowest prices on quality drugs anywhere because the government forces prices down to lower government expenditures. All the drug firms that put together high profit drug plans to fill their pockets are destroyed without question by the Canadian government. In the U.S. our congressional representatives steer thought from destroying excessive profit taking by the drug companies since they are dedicated to these drug companies for their own personal profit. Congressional Representatives enter congress with meager wealth and leave with excessive riches.

I simply bet ya if a person gained use of the investments of our congressional leaders they would find many cases of drug company investments who have very high drug prices on popular needed drugs that actually work to improve a persons health. Congress voted to provide drug companies a 20 year patent before generics could possibly be produced with a 5 year extension if certain conditions are met understanding that high drug prices would develop giving congressional insiders great profit making investment opportunities.

I hear now and again on news shows the patent time is currently 12 years but I haven’t seen this 12 year patent time period in “Wikipedia” or anywhere else. All I see are 20 year patent time frames. I searched around and discovered following the drug is invented and a patent applied it could take around 8 years to have FDA approved which leaves 12 years for the drugs to stay on a patent.

Which of our congressional representatives would vote against this time honored tradition of screwing U.S. Citizens in the behind by increasing patent times so they could increase their own personal cash value through outrageous drug prices?

So lets take the biological psoriasis drugs for example since they have only been around since 2003 or so. “Humira” was the initial biological patent approved by the FDA for the treating Rheumatoid Arthritis. Later on “Humira” was approved for the treatments of many other medical conditions including psoriasis.

If you have a 20 year patent on these drugs then “Humira” will soon be priced out of reach of most people until 2023 which was an enormous profit taking window for congressional representatives. “Skyrizi” that will be new this year in 2019 is priced around “$15,000” for a twelve months kit that will be 5 or 6 shots. “Humira” is injection and pill form. “Skyrizi” removes 90% of psoriasis with the initial two shots which are 4 weeks apart. “Skyrizi” will remain priced quite high until about 2039 when it includes a 20 year patent.

When Humira comes from patent in 2023 it’ll send the manufacturing of it to the generic drug companies and drop the cost to promote value which may mean everyone on Medicaid and Medicare could have a chance to be treated with it. All biological drug manufacturers will have to drop their prices and also to a reasonable level because ALL doctors will direct their patents to Humira leaving other drug companies with a product that can not be sold as a result of price. In “India” a common type of “Humira” soulja lean will be manufactured and the monthly cost is only $400 that will be only down a hundred or so from the discounted prices in the U.S.. After “Humira” goes off patent in the U.S. even the generic “India” brand will fall in price even further.

I read it might cost a drug company over a thousand dollars to produce a drug but this is “Bull Hicky” ;.For just one think a drug company isn’t a drug company without a team of researchers. In fact a drug company is just researchers. A drug company after it starts making a make money from the drugs they manufactured in the initial place needs to budget for a permanent research team to create future drug profits. The research team gets its paychecks from previous released drug sales always and forever and NO recouping of costs for the development of a fresh drug is ever needed. A drug company is just a huge laboratory full of scientists that receives a commission regularly to create new drugs and do constant experiments. No extra financial outputs are going on to drive drug prices through the roof.

Popular new releases of drugs are just total profit magnets for drug companies and congressional representatives. It’s like town or city your home is for making you think that the cost to deal with a concern will exceed the taxes already collected to cover the staff and resources to deal with the conditions that are actually funded.

The “Stock Act” was enacted on April 4th, 2012 which required every member of congress to post their investment transactions on the websites within 45 days of creating them for public viewing. Congressional representatives do not need their investments looked over nevertheless when public demand dictated so it become law to have their investments made public they’d to provide into the public demand and folded to it. After having a year congress went against public demand on April 15th 2013 and voted to kill the areas of what the law states that will make their investments public. Congress couldn’t fulfill themselves at the expense of U.S. Citizens with riches galore through insider trading which they think they have the right to do since there’s no legal entity that’ll punish them.

As Effective Drug Markets Grow Any Drugs Under Patents Sore In Price To The Point Only The Wealthy Can Afford Them. In 2012 The Drug Companies Decided Psoriasis Biological’s Were A Profit Maker In A Fast Growing Market. The Move Was Made To Raise The Prices So Extreme Profits Could Be Realized Through There Patent Monopoly Scheme Of Marketing To The Rich

Biological psoriasis drugs were priced lower in 2012 and insurance companies covered them if an affordable deductible was paid by someone who had a great job. After industry for biological,s started to develop industry became hijacked by the wealthy as an easy way to boost their personal values by increasing the costs and marketing these drugs to the wealthy and themselves that are the wealthy for massive profit taking. People have been getting their psoriasis drugs covered through their insurance companies were being dropped off their insurance plans. Although insurance carriers covered biological’s before 2012 low income Medicaid and Medicare patients still did not have use of these drugs. Medicare Part D prescription plan pays the majority of cost nevertheless the copay is $1200 to $5000 dollars which means most Medicare patients do not need use of biological’s.

There’s no other way you can look at it. “Epipen’s” were getting exactly the same treatment, they certainly were introduced at a lowered price then hijacked on the market only to the wealthy which would produce high profits with decreased production costs. I keep running in to the hearing aid conditions that were suppose to have been priced in to the tens and thousands of dollars then being reduced to under $700 that will be still to expensive and an arena of massive profit taking. Advanced computer parts are cheaper than hearing aids?

With one of these drug companies as is with any business who holds a monopoly on any needed or popular product through government mandate the higher prices only the wealthy can pay are dictated which means less production will soon be needed that means lower production costs and exactly the same or older profit levels are kept. Production at market demand means higher manufacturing costs with lower profit margins.

Posted on

Leave a Reply

Your email address will not be published. Required fields are marked *